Top 300 Pharmacy Drug Cards 22 vs. RxOrange Utilizzo e statistiche

The quickest, most efficient way for mastering critical facts about common drugs Perfect for NAPLEX and course review, McGraw Hill's 2022-2023 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. Each card includes: • Generic and common name • Dosage Forms • Approved Dose and Indications • Off-Label Use • Contraindications • Adverse Reactions • Drug Interactions • Monitoring Parameters • Medication Safety Issues and Black Box Warnings • Strong focus on patient safety Adverse reactions are organized by common, less common, and rare but serious to help you organize your thoughts for counseling patients No internet connection needed to view the full app. It is all ready for super quick image and information retrieval. This app is optimized for whatever size device you are using, either phone or tablet. Each card also features a photograph as well as important drug information. You can also search the entire text with our lightning fast search tool. The search tool shows you suggested words as you type so it is quick and helps with spelling issues. You can also add notes to each drug card, as well as bookmark drug cards as Know and Don't Know to help with studying. You also have the ability to change the text size for easier reading. This interactive app is based on the full content of McGraw-Hill’s 2022/2023 Top 300 Pharmacy Drug Cards. ISBN-13: 978-1260467345 ISBN-10: 1260467341 Editors: Jill M. Kolesar, PharmD, MS, BCPS, FCCP University Research Professor, Colleges of Pharmacy and Medicine Director, Precision Medicine Initiatives Markey Cancer Center University of Kentucky Lexington, Kentucky Lee C. Vermeulen, BSPharm, MS, FCCP, FFIP Chief Efficiency Officer UK HealthCare Professor of Medicine and Pharmacy University of Kentucky Lexington, Kentucky Disclaimer: This app is intended for the education of healthcare professionals and not as a diagnostic and treatment reference for the general population. Developed by Usatine Media, LLC Richard P. Usatine, MD, Co-President, Professor of Family & Community Medicine, Professor of Dermatology and Cutaneous Surgery, University of Texas Health Science Center San Antonio Peter Erickson, Co-President, Lead Software Developer

App Store di Apple
A pagamento
Settore Medico

Classifica degli store

- -

RxOrange

RxOrange provides full, Internet free, access to the FDA Orange Book with a thoughtful user interface and a unique set of features that you will find nowhere else, not even on the FDA web site. Questions that RxOrange can quickly answer. When does that drug go generic? One question that frequently gets asked by both patients and health care practitioners is ‘When will a generic come out for this drug’? RxOrange can predict an expiration date based on patent and exclusivity information from the Orange Book.* It also shows brand name products that have recently gone generic, so you can stay up to date as new generics become available. *Please note that unexpired patents, patent extension, and litigation can delay or expedite the actual date of generic competition. RxOrange provides a reasonable estimate based on available data, or an actual date if it is known. What generic products are therapeutically equivalent to the brand name drug? RxOrange can help you find suitable generic substitutes fast. Drug products are organized into brand and generic sections and alphabetized by manufacturer. The therapeutic equivalence (TE) code for each drug product is highlighted with a color (green, yellow, or red) to make interpreting the codes easy.** What products have recently been approved by the FDA? Dozens of new drug products are released each month by manufacturers. RxOrange will help you keep up to date on both brand and generic products as they become available. Check out the screenshots below! ** The therapeutic equivalence code, or TE code, provided by the FDA indicates whether a generic product can be substituted for its brand name counterpart. Products highlighted green are equivalent substitutes, yellow highlighting indicates no information is available and caution should be taken, and red highlighting indicates the product is NOT equivalent to the brand name product. A detailed explanation of each code is available in the detail view for each drug. Who made RxOrange? RxOrange has been written and designed by a pharmacist with the fast paced work environment of medical professionals in mind. Information is presented in a format that is intuitive, fast, and easy to use. This app will be useful for pharmacists, physicians, nurses, and any other health care professional that needs access to information about therapeutic substitution, product availability, and patent expiration. How often will this app be updated? RxOrange will be updated monthly coinciding with the monthly release of Orange Book data from the FDA. Each release version will trail with the year and month the database was compiled. (Example. The database in version 3.95.2101 will be compiled with the most recent data from January of 2021) Additional updates will include bug fixes and new features as they become available. Features in development for future releases -Listing of products that are considered NOT therapeutically equivalent -Have a feature you’d like to see? Tell me about it! Disclaimer Every effort has been made to ensure accuracy of the data provided by RxOrange. However, this app is not intended to be used to provide medical advice or make clinical decisions. Dabbling Badger LLC will not be held responsible for any errors or omissions in the content of the app provided. By downloading this app you will be agreeing to a standard licensed application end user license agreement that expresses the statement above in more legal detail.